Advanced Research in Epithelial–Mesenchymal Transition (EMT) in Cancers

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 62

Special Issue Editor


E-Mail
Guest Editor
1. Department of Anatomy-Histology-Embryology, School of Medicine, University of Patras, Rion, Greece
2. Department of Surgery, University Hospital of Patras, Rion, Greece
Interests: molecular biology of breast cancer; epithelial–mesenchymal transition (EMT); Hippo pathway; integrin-linked kinase (ILK)

Special Issue Information

Dear Colleagues,

A typical PubMed query using the search term “epithelial–mesenchymal transition” (“EMT”) retrieves over 48.000 articles, a number that is indicative of the great interest in this topic. EMT is a reversible transdifferentiation program whereby epithelial cells acquire the invasive, migratory mesenchymal phenotype. EMT normally occurs during embryonic development, as well as in wound healing as a physiological response to injury. This embryonic genetic program is hijacked by cancer cells for their own benefit, favoring the acquisition of metastatic capacity and resistance to therapy. Initially considered to be an on–off phenomenon, EMT is now viewed as a gradual transformation process that also produces epithelial–mesenchymal hybrids through partial EMT. Once the metastatic cells that have undergone EMT reach the site of distant metastasis, they are believed to undergo the reverse process of mesenchymal–epithelial transition (MET) in order to increase their proliferative capacity and facilitate metastatic outgrowth. Thus, cancer cells through EMT/MET processes acquire cellular plasticity and the ability to interconvert between intermediate epithelial–mesenchymal cell states in order to fulfill the various spatial and temporal requirements during the course of malignant progression and metastasis. Importantly, except from motility and invasion, EMT has been associated with chemoresistance, cancer stem cell properties, resistance to apoptosis, genomic instability, and metabolic reprogramming.

In this Special Issue, we welcome the submission of both original research and review articles focused on the latest progress and recent findings in all aspects of cancer-related EMT.

Dr. Ioanna Akrida
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epithelial–mesenchymal transition (EMT)
  • mesenchymal–epithelial transition (MET)
  • epithelial–mesenchymal plasticity (EMP)
  • tumor microenvironment
  • cell–extracellular matrix interactions
  • extracellular matrix remodeling
  • metastasis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop